Cargando…
The epidemiology and evolution of IgA nephropathy over two decades: A single centre experience
BACKGROUND AND OBJECTIVES: IgA nephropathy (IgAN) is the most common glomerulonephritis worldwide, with an incidence of 2.5 per 100,000 population per year. The 10-year risk of progression to end stage kidney disease (ESKD) or halving of eGFR is 26%. Here we aimed to collect a comprehensive dataset...
Autores principales: | Storrar, Joshua, Chinnadurai, Rajkumar, Sinha, Smeeta, Kalra, Philip A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436111/ https://www.ncbi.nlm.nih.gov/pubmed/36048745 http://dx.doi.org/10.1371/journal.pone.0268421 |
Ejemplares similares
-
A low rate of end-stage kidney disease in membranous nephropathy: A single centre study over 2 decades
por: Storrar, Joshua, et al.
Publicado: (2022) -
Native and transplant kidney histopathological manifestations in association with COVID-19 infection: A systematic review
por: Jeyalan, Vishnu, et al.
Publicado: (2021) -
Genetic polymorphism in C3 is associated with progression in chronic kidney disease (CKD) patients with IgA nephropathy but not in other causes of CKD
por: Ibrahim, Sara T., et al.
Publicado: (2020) -
Calciphylaxis in end-stage kidney disease: outcome data from the United Kingdom Calciphylaxis Study
por: Chinnadurai, Rajkumar, et al.
Publicado: (2021) -
The Role of PLA2R in Primary Membranous Nephropathy: Do We Still Need a Kidney Biopsy?
por: McDonnell, Thomas, et al.
Publicado: (2023)